Receipt of zoster vaccine reduces probability of new dementia diagnosis over 7-year period by 3.5 percentage points. HealthDay News — Zoster vaccination seems to have a dementia-preventing or dementia ...

Findings showed patients on setmelanotide saw a mean BMI reduction of 16.5% from baseline compared with a 3.3% increase for those on placebo at week 52. Topline data were announced from a phase 3 ...

Patients who underwent NeuroSAFE during nerve-sparing surgery showed improvement in erectile function at 12 months and urinary continence at 3 months. HealthDay News — Use of the NeuroSAFE ...

A survey conducted by the Preservative Freedom Coalition, asked 558 patients with glaucoma or ocular hypertension how they felt about their treatments, the future of their eye health, trust in their ...

Molecular structures of spironolactone (416.57 g/mol) and canrenone (340.45 g/mol). Given its widespread use in clinical practice, SPI features in several pharmaceutical formulations, including ...

and Sun Pharmaceutical Industries Ltd. announced that SPARC has licensed out Xelpros (Latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market. On 1 August 2015, Sun Pharma ...

More importantly, Sun has a solid unfolding pipeline in specialty business which includes Elepsia, Bromsite, MK3222 – Tildrakizumab Infusmart, Xelpros, and Dexasite. This will drive its profitability ...

NCX 470, a nitric oxide-donating bimatoprost, is under investigation for lowering IOP in glaucoma and ocular hypertension. The Whistler Phase 3b trial involved 18 participants and focused on aqueous ...

Increased mass manufacturing and the pervasive use of plastics in many facets of daily life have had detrimental effects on the environment. As a result, these worries heighten the possibility of ...